International Clinical Trial: G-DISCOTEQ: A Phase 2 Trial of Gemcitabine-Docetaxel Intravesical Synchronous CO-administration Therapeutic Efficacy Quantification in patients with BCG unresponsive high-risk, non-muscle-invasive bladder cancer (ANZUP 2502)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000234314) titled 'G-DISCOTEQ: A Phase 2 Trial of Gemcitabine-Docetaxel Intravesical Synchronous CO-administration Therapeutic Efficacy Quantification in patients with BCG unresponsive high-risk, non-muscle-invasive bladder cancer (ANZUP 2502)' on Feb. 24.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Blinded (masking used) Assignment: Single group Type of endpoint: Safety/efficacy

Primary Sponsor: South Metropolitan Health Service

Condition: non muscle invasive bladder cancer non muscle invasive bladder cancer Cancer - Bladder

Intervention: Cohort A: People with ca...